1,958 hedge funds and large institutions have $144B invested in Pfizer in 2016 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 884 increasing their positions, 762 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less first-time investments, than exits

New positions opened: | Existing positions closed:

1% less funds holding

Funds holding: 1,9871,958 (-29)

5% less capital invested

Capital invested by funds: $152B → $144B (-$8.2B)

18% less funds holding in top 10

Funds holding in top 10: 285234 (-51)

Holders
1,958
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
234
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.25B
Puts
$2.33B
Net Calls
Net Calls Change

Top Buyers

1 +$337M
2 +$327M
3 +$270M
4
Renaissance Technologies
Renaissance Technologies
New York
+$231M
5
JP Morgan Chase
JP Morgan Chase
New York
+$176M
Name Holding Trade Value Shares
Change
Change in
Stake
676
$6.58M
677
$6.58M
678
$6.57M
679
$6.57M
680
$6.55M
681
$6.54M
682
$6.52M
683
$6.47M
684
$6.45M
685
$6.43M
686
$6.42M
687
$6.41M
688
$6.39M
689
$6.37M
690
$6.35M
691
$6.33M
692
$6.32M
693
$6.31M
694
$6.29M
695
$6.29M
696
$6.26M
697
$6.22M
698
$6.2M
699
$6.17M
700
$6.15M